EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interventional radiological therapies in colorectal hepatic metastases

Sai Swarupa R Vulasala, Patrick D Sutphin, Samira Kethu, Nirmal K Onteddu, Sanjeeva P Kalva

Frontiers in Oncology · 30.05.2023 · 13

DOI: 10.3389/fonc.2023.963966 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 30.05.2023. Verfasst von Sai Swarupa R Vulasala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Florida College of Medicine, Jacksonville, FL, United States. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal malignancy is the third most common cancer and one of the prevalent causes of death globally. Around 20-25% of patients present with metastases at the time of diagnosis, and 50-60% of patients develop metastases in due course of the disease. Liver, followed by lung and lymph nodes, are the most common sites of colorectal cancer metastases. In such patients, the 5-year survival rate is approximately 19.2%. Although surgical resection is the primary mode of managing colorectal cancer metastases, only 10-25% of patients are competent for curative therapy. Hepatic insufficiency may be the aftermath of extensive surgical hepatectomy. Hence formal assessment of future liver remnant volume (FLR) is imperative prior to surgery to prevent hepatic failure. The evolution of minimally invasive interventional radiological techniques has enhanced the treatment algorithm of patients with colorectal cancer metastases. Studies have demonstrated that these techniques may address the limitations of curative resection, such as insufficient FLR, bi-lobar disease, and patients at higher risk for surgery. This review focuses on curative and palliative role through procedures including portal vein embolization, radioembolization, and ablation. Alongside, we deliberate various studies on conventional chemoembolization and chemoembolization with irinotecan-loaded drug-eluting beads. The radioembolization with Yttrium-90 microspheres has evolved as salvage therapy in surgically unresectable and chemo-resistant metastases.

Schlagwörter

Stichwörter der Autor:innen

DEBIRI-TACETACETAREcolorectal metastaseshepatic colorectal metastasesinterventional oncologyinterventions in colorectal metastasespercutaneous ablation

Autor:innen und Institutionen

  • Department of Radiology, University of Florida College of Medicine, Jacksonville, FL, United States.
  • Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Department of Microbiology and Immunology, College of Arts and Sciences, University of Miami, Coral Gables, FL, United States.
  • Department of Hospital Medicine, Flowers Hospital, Dothan, AL, United States.

Zitieren

APA

Vulasala, S. S. R., Sutphin, P. D., Kethu, S., Onteddu, N. K., & Kalva, S. P. (2023). Interventional radiological therapies in colorectal hepatic metastases. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.963966

Vancouver

Vulasala SSR, Sutphin PD, Kethu S, Onteddu NK, Kalva SP. Interventional radiological therapies in colorectal hepatic metastases. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.963966

BibTeX
@article{Vulasala2023,
  author = {Vulasala, Sai Swarupa R and Sutphin, Patrick D and Kethu, Samira and Onteddu, Nirmal K and Kalva, Sanjeeva P},
  title = {Interventional radiological therapies in colorectal hepatic metastases},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.963966}
}
Kostenlos starten →